Anzeige
INTRODUCTION project G.docx
INTRODUCTION project G.docx
INTRODUCTION project G.docx
Nächste SlideShare
Presentation on covid 19Presentation on covid 19
Wird geladen in ... 3
1 von 3
Anzeige

Más contenido relacionado

Similar a INTRODUCTION project G.docx(20)

Anzeige

INTRODUCTION project G.docx

  1. INTRODUCTION Covid-19 or coronavirus disease-2019 is caused by SARS-CoV-2, a newly emergent coronavirus that was first recognised in Wuhan, China in December 2019. Coronavirus is linked to SARS (Severe Acute Respiratory Syndrome) virus and belongs to a large group of positive stranded RNA virus (+ssRNA). Coronavirus disease (Covid-19) caused by SARS-CoV-2 was declared as a global pandemic by World Health Organisation (WHO) on 30th January 2020, the first day India had reported its first confirmed case of Covid-19. The WHO directed all countries to prepare for containment, including active surveillance, early detection, isolation and case management, contact tracing and prevention of onward spread of infection. Common symptoms of Covid-19 include fever, cough, fatigue, shortness of breath and loss of smell and taste. Some people develop Acute Respiratory Distress Syndrome (ARDS), multi-organ failure, septic shock and blood clots. The incubation period ranges from 2-14 days with an average of 5 days. The mode of transmission can occur through direct, indirect or close contact with infected people through secretions such as saliva, respiratory secretions while sneezing or coughing and through fomites.
  2. In India, the first case of covid-19 was reported on 30th January in Kerala. India currently has the largest number of confirmed cases in Asia. A Covid-19 national lockdown was enforced from 24th March 2020 which was gradually unlocked in 6 phases till November 2020. The first case of Covid-19 in the Indian state of Assam was reported on 31st March 2020. The districts like Kamrup (M), Nagaon, Dibrugarh were worst affected. Globally, as of 19th November 2021, there has been 255,324,963 confirmed cases of Covid-19 including 5,127,696 deaths reported to WHO. India, as of 21st November 2021 reported 34,044,751 confirmed cases of Covid-19 including 465,662 deaths as per the Ministry of Health and Family Welfare, Government of India. And the Indian state of Assam, as of 21st November 2021 reported 580657 confirmed cases, including 5502 deaths, with the district of Assam- Kamrup (Metro) where Guwahati city is situated reported 20663 confirmed cases of Covid-19. The corona virus has infected millons of people all over the world ,in addition to that millons of people have lost their lives . It is a very contagious and virulent virus, therefore it is very essential for acquiring immunity against the COVID19 virus. Vaccine are the most important public health measures and most effective strategy For control the COVID 19 pandemic . Ever since the outbreak Researcher all over the world have been working constantly to develop vaccines that will work effectively against the virus. While the vaccines are been develop at a fastpace , they also require rigorous testings. clinical trials were done to ensure they meet the benchmark for the safety and efficiency of international stantards.
  3. After successful clinical trial and W.H.O approval of Covid 19 vaccine . Indian government have launched the largest vaccination drive in the world ,Government are providing free of cost Covid 19 vaccine . Two of the widely used Covid 19 vaccine in india are Covishield and Covaxin which was approved for administration in adult population (18+).Covishield is a recombinant chimpanzee adenovirus vector vaccine developed by Astrazeneca and Covaxin is whole viron inactived vaccine developed by Bharat Biotech. Recently government approved vaccine for age group between 15-18years and 3rd dose Covid vaccines for Health workers and senior citizen (60+).Government has also approved emergency administration of Sputnik V, Zydus Cadilla, Moderna, Johnson & Johnson. Till date government of India has successfully administered more than 1.5 billion Covid 19 vaccines. In Assam government has successfully administered 3 crore vaccine dose as of 1st January2022. While the availability and distribution of the vaccines remains a challenge, even in places where vaccines are made available, there is a great controversy about Covid 19 vaccine among the general population. A proportion of the people are still hesitating to take Covid 19 vaccine. Thus, this study is being conducted with the objective to assess the present state of knowledge,attitude,practices and also to know the expectation and preferences regarding the Covid 19 vaccination among the people residing in Guwahati city because it is crucial for government and policy makers to address all barrier regarding vaccine distribution, administration and safety
Anzeige